We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » BMS Faces Wider Criminal Probe Into Plavix Settlement
BMS Faces Wider Criminal Probe Into Plavix Settlement
October 31, 2006
Bristol-Myers Squibb’s (BMS) problems continue as the company lost substantial revenue from generic competition to its blood thinner Plavix and now faces potentially broader criminal charges related to the drug.